950,000
Participants
Start Date
May 31, 2008
Primary Completion Date
July 31, 2025
Study Completion Date
August 1, 2025
There is no intervention associated with the parent MNHR study. For the MNHR COVID sub-study, participants will be asked to provide a blood specimen at or near delivery.
"There is no intervention associated with the parent MNHR study~For the MNHR COVID sub-study, each woman will be asked to provide a blood specimen of approximately 3-5 cc at or near delivery (at delivery or 14 days after) to be tested for COVID-19 antibodies. The person collecting the specimen will be a trained member of the registry staff. The ZEUS ELISA SARS-CoV-2 IgG Test System will be used and run at each site. RTI International will provide central quality support of the analyses."
ICDDRB, Dhaka
Columbia University, New York
Thomas Jefferson University, Philadelphia
University of Virgina, Charlottesville
University of North Carolina, Chapel Hill
University of Alabama at Birmingham, Birmingham
The Aga Khan University, Karachi
University of Colorado Denver, Aurora
Indiana University School of Medicine, Indianapolis
Boston University, Boston
Kinshasa School of Public Health, Kinshasa
KLE Academy of Higher Education and Research, Belagavi
Lata Medical Research Foundation, Nagpur
University Teaching Hospital, Lusaka
Institute for Nutrition of Central America and Panama (INCAP), Guatemala City
NICHD Global Network for Women's and Children's Health
NETWORK